Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Meibomian gland acinar cells are specialized secretory cells located within the tarsal plates of the eyelids that are responsible for the synthesis and secretion of meibum, a complex mixture of lipids (Butovich, 2017, "The Meibomian Gland: Lipid Composition, Lipid Biosynthesis, and Pathophysiology"). This lipid secretion forms the outermost layer of the tear film, which is essential for preventing tear evaporation and maintaining ocular surface health (Knop et al., 2011, "The international workshop on meibomian gland dysfunction"). The lipid synthesis pathways within these cells involve the production of wax esters, sterol esters, and polar lipids through the action of various enzymes such as fatty acid elongases (ELOVL4) and wax synthases (AWAT2). Dysfunction in these cells or their metabolic pathways leads to Meibomian Gland Dysfunction (MGD), a primary cause of evaporative dry eye disease characterized by altered lipid composition and gland obstruction (Nelson et al., 2011, "The international workshop on meibomian gland dysfunction: report of the definition and classification subcommittee"). Therapeutic strategies targeting this system include anti-inflammatory agents to preserve acinar function, lipid replacements like perfluorohexyloctane to supplement deficient meibum, and macrolide antibiotics like azithromycin which may stimulate lipid accumulation (Liu et al., 2014, "Azithromycin promotes meibomian gland epithelial cell differentiation and lipid accumulation").
Modulation of lipid synthesis enzymes (e.g., AWAT2, FAR1), reduction of ductal and acinar inflammation, and physical supplementation of the tear film lipid layer to prevent evaporation.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Meibomian gland acinar cells and lipid synthesis pathways.